BIM
LGND icon

BlackRock Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

BlackRock Investment Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$9.8M Buy
154,664
+27,351
+21% +$1.73M 0.01% 1125
2016
Q3 		$8.11M Sell
127,313
-151
-0.1% -$11.1K 0.01% 1142
2016
Q2 		$9.48M Buy
127,464
+16,916
+15% +$1.26M 0.01% 993
2016
Q1 		$7.38M Buy
110,548
+3,202
+3% +$195K 0.01% 1113
2015
Q4 		$7.26M Buy
107,346
+628
+0.6% +$38.8K 0.01% 1131
2015
Q3 		$5.7M Sell
106,718
-1,379
-1% -$83.7K 0.01% 1294
2015
Q2 		$6.8M Buy
108,097
+4,715
+5% +$257K 0.01% 1256
2015
Q1 		$4.97M Buy
103,382
+1,718
+2% +$65.8K 0.01% 1365
2014
Q4 		$3.38M Sell
101,664
-6,362
-6% -$207K ﹤0.01% 1662
2014
Q3 		$3.17M Sell
108,026
-1,084
-1% -$36K ﹤0.01% 1671
2014
Q2 		$4.24M Buy
109,110
+12,047
+12% +$489K 0.01% 1514
2014
Q1 		$4.07M Buy
97,063
+734
+0.8% +$30.6K 0.01% 1521
2013
Q4 		$3.16M Buy
96,329
+15,905
+20% +$518K ﹤0.01% 1684
2013
Q3 		$2.17M Buy
80,424
+4,442
+6% +$125K ﹤0.01% 1897
2013
Q2 		$1.77M Buy
+75,982
New +$1.37M ﹤0.01% 1938

Other funds holding LGND

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock Investment Management's LGND Position: Q4 2016 in Review

BlackRock Investment Management increased its Ligand Pharmaceuticals (LGND) stake by 21% in Q4 2016, buying an estimated $1.73M and bringing the position to 154,664 shares worth $9.8M. The position accounts for 0.01% of the portfolio, ranked #1125.

BlackRock Investment Management first reported a position in LGND in Q2 2013 and has held it in 15 quarters since. 270 funds tracked by Wall St. Rank hold LGND as of Q4 2016.

  • BlackRock Investment Management held 154,664 shares of Ligand Pharmaceuticals worth $9.8M as of Q4 2016.
  • BlackRock Investment Management bought 27,351 Ligand Pharmaceuticals shares in Q4 2016, an estimated $1.73M.
  • Ligand Pharmaceuticals made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1125 holding.
  • BlackRock Investment Management first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 270 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.